[ad_1]
Russia denies such accusations and demands that Bratislava return 200,000. vaccine dose. The dispute could slow down Russia’s efforts to inject its vaccine into the European Union, Bloomberg reports. In Slovakia, the Russian drug COVID-19 has even sparked a political crisis.
The Russian Direct Investment Fund (RTIF), created by the Government of the Russian Federation, has asked the Slovak authorities to reimburse Russia a batch of Sputnik V coronavirus vaccine for use in other countries. This information is available on the vaccine microblog from your tweet.
The report claims that the Slovakian laboratory where the batch of Russian vaccine doses received was tested is not part of the official European Union (EU) network of laboratories, which allegedly violated the terms of the contract.
“Unfortunately, the Slovak State Institute for Medicines Control has tested the Sputnik V laboratory, which is not part of the network of official EU drug control laboratories, although it had the opportunity to contact one of these laboratories. There was breach of contract and, in a sense, sabotage, ”RIF Novosti quoted RTIF as saying.
According to vaccine manufacturers, the Slovak regulator has launched a disinformation campaign against Sputnik V.
In Moscow, the institution is believed to be “planning more provocations” in the future.
2) Reports that Sputnik V vaccine in Slovakia is somehow different from Sputnik V in clinical trials citing anonymous sources are false. Unfortunately, we also expect fake news and additional provocations from the enemies of Sputnik V in Slovakia trying to undermine the vaccine.
– Sputnik V (@sputnikvaccine) April 7, 2021
RTIF noted that a letter requesting the return of a batch of vaccine doses had been sent to the Slovak authorities on April 6. Foundation staff also deny reports that the Russian vaccine for Slovakia is different from the vaccine tested in clinical trials.
RTIF considers this information to be unreliable, as the production of all vaccine lots is strictly controlled at the Gamalay Center.
This week it was reported that the Slovak State Drug Control Institute had investigated the Russian-made Sputnik V vaccine, which had been purchased by the previous government, and concluded that it was not identical to the one praised by the authoritative journal The Lancet.
This was announced by the Slovak publication Dennik N.
The state institute has not made the decision to recommend vaccinating the country’s population with a Russian vaccine because it does not have enough information to do so. This is a joint opinion of the Institute and the Ministry of Health.
It is emphasized that Slovak inspectors cannot evaluate the vaccine as comprehensively as the European Medicines Agency.
The Institute states that studies have been conducted on the sterility, pyrogenicity, pH, transparency, color, abnormal toxicity, specific activity, visible mechanical impurities, specific protein concentration, and appearance of the vaccine.
But these tests alone do not allow any definitive conclusions to be drawn about the efficacy and safety of the vaccine.
The Slovak Institute also did not receive all the documents related to the production and safety of the vaccine necessary for the evaluation.
A very important discovery was the fact that the vaccine imported to Slovakia is not identical to the vaccine, the results of which were discussed in the prestigious scientific journal The Lancet. They are not like those used in other countries.
So far, the Slovak authorities have based their decision to buy Russian vaccines on the results of The Lancet study.
Following an investigation by the Slovak State Institute, the Slovak Ministry of Health approached another laboratory with a request to verify the safety of the vaccine, but the results will only be known at the end of the week.
Slovakia received the first batch of 200,000 doses of the Sputnik V vaccine in early March. The country ordered a total of 2 million. dosage of this Russian drug, which has not yet been approved by the European Medicines Agency (EMA).
Delphi recalls that the collusion in the purchase of the Russian vaccine against the coronavirus pandemic Sputnik V in Slovakia caused a political crisis.
The cabinet of former Prime Minister Igor Matovich became the first European government to fail due to its actions in managing the coronavirus pandemic.
The political crisis began with the revelation of a secret deal to buy 2 million. doses of the Russian vaccine “Sputnik V”. This move by the populist Prime Minister I. Matovičius provoked the outrage of the coalition partners.
Two of the coalition partners, Freedom and Solidarity (SaS) and For the People, called for the resignation of the prime minister to preserve a coalition with a strong majority in parliament.
The crisis has paralyzed the government of one of the European Union countries most affected by the pandemic.
Slovakia and Hungary are the only EU countries that have agreed to use a Russian vaccine. However, on Thursday it was announced that Germany could start negotiations with Russia on the supply of Sputnik V. This was stated by German Health Minister Jens Spahn.
“We have to understand when we can expect batches of vaccines,” he said.
According to the minister, the European Medicines Agency (EMA) declared the day before that there can be no centralized supplies from “third-party” vaccine manufacturers, so it is necessary to understand when Russian shipments of coronavirus vaccines can be expected.
Germany’s southern Bavarian region said on Wednesday it had signed a preliminary agreement on acquiring the Russian vaccine “Sputnik V” once it is approved by European regulators.
If approved by the EVA, Bavaria is expected to receive around 2.5 million euros in the coming months. their doses through a company based in the federal city of Ilertisen, Bavarian Prime Minister Markus Soder said.
The German government announced last month that it would be open to vaccinating the population with the Sputnik V vaccine if it is approved by the EVA.
Chancellor Angela Merkel, commenting on Berlin’s position on Sputnik V, said that Germany “should use any vaccine that has been approved” by the European Medicines Agency.
Last month, the Amsterdam-based EVA launched an ongoing review of Sputnik V, an important step in approving this first non-Western product for use in a 27-nation bloc.
Still, the Russian drug has come under fire in the West, and French Foreign Minister Jean-Yves Le Drian has accused Russia and China of using their vaccines to increase their influence abroad.
Russia registered Sputnik V in August, before large-scale clinical trials were carried out, so many experts feared the move was too hasty.
It is strictly forbidden to use the information published by DELFI on other websites, in the media or elsewhere, or to distribute our material in any way without consent, and if consent has been obtained, it is necessary to cite DELFI as the source. .
[ad_2]
